2-Aminoadamantane-2-carboxylic acid (CAS 42381-05-5)
QUICK LINKS
2-Aminoadamantane-2-carboxylic acid, characterized by its unique geminally functionalized structure, stands out as an achiral, tricycloaliphatic aminocarboxylic acid. This compound is noted for its ability to disrupt the normal transportation processes of amino acids, such as L-leucine and L-methionine, specifically targeting their uptake into Ehrlich ascites tumor cells. This inhibition mechanism is pivotal in the context of biochemical research, as it allows scientists to explore the fundamental aspects of cellular transport mechanisms and amino acid metabolism. The molecule′s distinctive tricyclic framework, combined with its functional groups, offers a robust tool for dissecting the nuances of cell membrane permeability and transport protein interactions. Consequently, 2-Aminoadamantane-2-carboxylic acid serves as a valuable probe in the study of cellular processes, aiding in the elucidation of the intricate dynamics of amino acid transport and its regulation within cellular environments. This exploration contributes significantly to our understanding of cellular nutrition and the metabolic pathways critical to cell growth and maintenance, thereby facilitating advancements in biochemical and molecular biology research fields.
2-Aminoadamantane-2-carboxylic acid (CAS 42381-05-5) References
- Potential latentiation forms of biologically active compounds based on action of leucine aminopeptidase. Dipeptide derivatives of the tricycloaliphatic alpha-amino acid, adamantanine. | Nagasawa, HT., et al. 1975. J Med Chem. 18: 826-30. PMID: 1159700
- Synthesis and biological studies of novel neurotensin(8-13) mimetics. | Hong, F., et al. 2002. Bioorg Med Chem. 10: 3849-58. PMID: 12413837
- Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity. | Horvat, S., et al. 2006. J Med Chem. 49: 3136-42. PMID: 16722632
- Novel insights into GPCR-peptide interactions: mutations in extracellular loop 1, ligand backbone methylations and molecular modeling of neurotensin receptor 1. | Härterich, S., et al. 2008. Bioorg Med Chem. 16: 9359-68. PMID: 18809332
- A systems approach towards an intelligent and self-controlling platform for integrated continuous reaction sequences. | Ingham, RJ., et al. 2015. Angew Chem Int Ed Engl. 54: 144-8. PMID: 25377747
- The Synthesis of α,α-Disubstituted α-Amino Acids via Ichikawa Rearrangement. | Szcześniak, P., et al. 2016. J Org Chem. 81: 1057-74. PMID: 26726732
- The route from problem to solution in multistep continuous flow synthesis of pharmaceutical compounds. | Bana, P., et al. 2017. Bioorg Med Chem. 25: 6180-6189. PMID: 28087127
- A supramolecular self-assembly strategy for upconversion nanoparticle bioconjugation. | Sun, Y., et al. 2018. Chem Commun (Camb). 54: 3851-3854. PMID: 29594291
- Design, Synthesis, and In Vitro Evaluation of Novel Histone H3 Peptide-Based LSD1 Inactivators Incorporating α,α-Disubstituted Amino Acids with γ-Turn-Inducing Structures. | Ota, Y., et al. 2018. Molecules. 23: PMID: 29734782
- Continuous Manufacturing in Pharmaceutical Process Development and Manufacturing. | Burcham, CL., et al. 2018. Annu Rev Chem Biomol Eng. 9: 253-281. PMID: 29879381
- 2-Aminoadamantane-2-carboxylic acid, a rigid, achiral, tricyclic alpha-amino acid with transport inhibitory properties. | Nagaswa, HT., et al. 1973. J Med Chem. 16: 823-6. PMID: 4725929
- Synthesis and transport applications of 3-aminobicyclo[3.2.1] octane-3-carboxylic acids. | Christensen, HN., et al. 1983. J Med Chem. 26: 1374-8. PMID: 6413692
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
2-Aminoadamantane-2-carboxylic acid, 500 mg | sc-306873 | 500 mg | $900.00 |